{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=All&page=92", "query": { "condition": "All", "page": 92 }, "page_size": 10 }, "pagination": { "page": 92, "page_size": 10, "total_count": 2136, "total_pages": 214, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=All&page=93&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=All&page=91&page_size=10" }, "source": "local", "last_synced_at": "2026-11-03T20:46:40.498Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06171750", "title": "Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor", "Cutaneous Squamous Cell Carcinoma", "Cutaneous Tumor", "Malignant Solid Tumor", "Metastasis to Soft Tissue", "Metastatic Solid Tumor", "Non Small Cell Lung Cancer", "Solid Tumor", "Subcutaneous Tumor" ], "interventions": [ { "name": "Cemiplimab", "type": "DRUG" }, { "name": "tolododekin alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ankyra Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 97, "start_date": "2024-01-19", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-11-03T20:46:40.498Z", "location_count": 4, "location_summary": "Bethesda, Maryland • Boston, Massachusetts • Portland, Oregon + 1 more", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Portland", "state": "Oregon" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06171750" }, { "nct_id": "NCT05846282", "title": "Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Allostatic Load", "Health Complaints", "Internalizing Mental Health Symptoms" ], "interventions": [ { "name": "STRIVE", "type": "BEHAVIORAL" }, { "name": "Study Skills", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 504, "start_date": "2023-01-09", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-10-16T01:13:15.544Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05846282" }, { "nct_id": "NCT04276870", "title": "Orphan Indications for CD19 Redirected Autologous T Cells", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infants With Very High Risk KMT2A B-ALL", "Patients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation", "Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL" ], "interventions": [ { "name": "Murine CART19", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Stephan Grupp MD PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "0 Years to 29 Years" }, "enrollment_count": 133, "start_date": "2020-03-12", "completion_date": "2037-03-10", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-10-15T02:14:29.114Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04276870" }, { "nct_id": "NCT06130995", "title": "Relugolix + Enzalutamide Study in High-Risk Prostate Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Androgen Deprivation Therapy", "Locally Advanced Prostate Cancer" ], "interventions": [ { "name": "Relugolix and Enzalutamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 46, "start_date": "2024-12-26", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2026-03-05", "last_synced_at": "2026-10-14T03:12:13.667Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT06130995" }, { "nct_id": "NCT05672108", "title": "Phase II Trial of Lung Chemoemobolization", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colon Cancer", "Endobronchial Metastases", "Lung Metastases From Any Primary", "Lung Non-Small Cell Carcinoma", "Mediastinal Neoplasm", "Pleural Neoplasm", "Sarcoma" ], "interventions": [ { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Ethiodized Oil", "type": "DRUG" }, { "name": "Mitomycin", "type": "DRUG" }, { "name": "Transarterial Chemoembolization", "type": "PROCEDURE" }, { "name": "Tris-acryl Gelatin Microspheres", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "DEVICE" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2023-05-12", "completion_date": "2027-10-28", "has_results": false, "last_update_posted_date": "2026-03-05", "last_synced_at": "2026-10-14T19:38:49.573Z", "location_count": 2, "location_summary": "Duarte, California • New York, New York", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05672108" }, { "nct_id": "NCT05068232", "title": "Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Extensive-stage Small-cell Lung Cancer", "Lung Cancer", "Small-cell Lung Cancer" ], "interventions": [ { "name": "Ablative Radiation", "type": "RADIATION" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Durvalumab", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2022-08-19", "completion_date": "2027-10-01", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-10-16T01:58:34.798Z", "location_count": 2, "location_summary": "Chicago, Illinois • Madison, Wisconsin", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05068232" }, { "nct_id": "NCT07219251", "title": "Engagement of Veterans With Lung Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Adenocarcinoma", "Lung Adenocarcinoma With Bronchiolo-alveolar Feature", "Lung Cancer (NSCLC)", "Lung Cancer, Non-Small Cell", "Lung Cancer, Small Cell", "Lung Carcinoma" ], "interventions": [ { "name": "Lay Health Worker (LHW) Planning", "type": "BEHAVIORAL" }, { "name": "Usual Care Group", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Palo Alto Veterans Institute for Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 194, "start_date": "2026-02-27", "completion_date": "2032-12-31", "has_results": false, "last_update_posted_date": "2026-03-03", "last_synced_at": "2026-07-29T06:59:53.895Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07219251" }, { "nct_id": "NCT07433660", "title": "WellSpan-THRIVE Cancer QOL Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative", "Cancer (Advanced Stage)", "Cancer (Solid Tumors)", "Cancer (With or Without Metastasis)", "Cancer - Ovarian", "Cancer Abdomen" ], "interventions": [], "intervention_types": [], "sponsor": "WellSpan Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2026-02", "completion_date": "2031-12", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-07-30T10:36:42.210Z", "location_count": 5, "location_summary": "Chambersburg, Pennsylvania • Ephrata, Pennsylvania • Gettysburg, Pennsylvania + 2 more", "locations": [ { "city": "Chambersburg", "state": "Pennsylvania" }, { "city": "Ephrata", "state": "Pennsylvania" }, { "city": "Gettysburg", "state": "Pennsylvania" }, { "city": "Lebanon", "state": "Pennsylvania" }, { "city": "York", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07433660" }, { "nct_id": "NCT06956690", "title": "A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Breast Cancer", "Melanoma (Skin)", "Non Small Cell Lung Cancer" ], "interventions": [ { "name": "ENV-501", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Hummingbird Bioscience", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2025-12-17", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-07-27T08:57:43.544Z", "location_count": 5, "location_summary": "La Jolla, California • Indianapolis, Indiana • Farmington Hills, Michigan + 2 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Farmington Hills", "state": "Michigan" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06956690" }, { "nct_id": "NCT06275360", "title": "Repositioning Immunotherapy in VetArans With Lung Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Nivolumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2024-03-01", "completion_date": "2030-03-31", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-07-30T05:34:37.857Z", "location_count": 7, "location_summary": "West Haven, Connecticut • Washington D.C., District of Columbia • Indianapolis, Indiana + 4 more", "locations": [ { "city": "West Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06275360" } ] }